| Followers | 308 |
| Posts | 23811 |
| Boards Moderated | 1 |
| Alias Born | 01/30/2007 |
Saturday, December 18, 2021 1:32:26 PM
This deal raised our awareness with additional institutional investors. We met with about 30 investors and our banks spoke with about 150 in total. We expect to gain three additional research analysts – Deutsche Bank, SVB Leerink and Canaccord – early next year.
We are very excited entering 2022. We expect another year of strong growth, and we’re progressing on making the Clover Assistant even more powerful and extending its capabilities further, while leveraging our platform to drive impressive operating synergies over time. Thanks for being on this journey with us. Vivek & Andrew $CLOV
We are very excited entering 2022. We expect another year of strong growth, and we’re progressing on making the Clover Assistant even more powerful and extending its capabilities further, while leveraging our platform to drive impressive operating synergies over time. Thanks for being on this journey with us. Vivek & Andrew $CLOV
Recent CLOV News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 01:47:43 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 08:50:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/12/2026 08:16:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2026 12:06:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 08:06:52 PM
- Clover Health Reports First Quarter 2026 Results • GlobeNewswire Inc. • 05/06/2026 08:05:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/28/2026 08:09:30 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2026 08:08:42 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:06:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 08:19:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/17/2026 12:25:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2026 08:09:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2026 08:07:01 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2026 11:46:26 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 04/09/2026 10:12:51 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2026 10:03:13 PM
- Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026 • GlobeNewswire Inc. • 04/08/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2026 08:28:10 PM
- Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership • GlobeNewswire Inc. • 04/07/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:59:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:34:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:31:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:25:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:20:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2026 12:32:45 PM

